Modi slides - National Confidential Enquiry into Patient Outcome
Download
Report
Transcript Modi slides - National Confidential Enquiry into Patient Outcome
Royal College of Paediatrics and Child Health
A mixed bag: an enquiry into
the care of hospital patients
receiving parenteral nutrition
Neena Modi
Vice President, Science & Research
Royal College of Paediatrics & Child Health
Professor of Neonatal Medicine
Imperial College London
Disclosures
Views of Expert Group members and advisors
sought
Neonatal clinician in a tertiary centre
Lead a research programme involving newborn
nutrition
Advised the Chief Pharmacist’s survey of
neonatal PN in 2008/9
What we knew
Essential is the smallest, sickest
babies
The target is growth, not
correction of malnutrition
Standard regimens feasible
Often Partial (not Total) PN,
bridging the gap to full milk feeds
Documentation poor and
variable
Prescribing and dispensing
processes variable
Complications common
Babies are neither small
children nor adults
Some 1,500 to 3,000 babies
receive PN in the UK each year
Confidential enquiries
“The purpose of a confidential enquiry is to
detect areas of deficiency in clinical practice
and devise recommendations to resolve
them; enquiries can also make suggestions
for future research programmes”
24%
12 babies
Documentation
Adequacy of first Parenteral Nutrition
Key findings
“Good practice”, defined as a “standard that you would
accept from yourself, your trainees and your institution”,
identified in 24% (62/264) of neonatal cases
Delay in recognising need for PN in 28%
Delay in starting PN once decision made in 17%
Poor documentation in 72%
First PN provided considered inadequate in 37%
Metabolic monitoring inadequate in 19%
Principal recommendations
Prompt consideration of need for PN, start without delay
First PN must be appropriate to neonate’s needs
Close monitoring essential
Neonatal units should have policies for documentation
Team approach
Consensus on best PN practice
Education, audit and training needed
NICE guidelines for nutritional support needed
Central hospital record of patients receiving PN
Attention to vascular line care
What was missing?
Details of prescribing and dispensing practice (Chief
Pharmacist’s 2009 Study)
Denominators (how many babies should have received
PN?)
Controls (were complications reliably attributable to PN?)
Details of concurrent milk feeds (was nutritional support
really poor?)
A sense of what variation in practice there was among
assessors (was the enquiry consistent?)
Acknowledgement that the evidence base is poor
Possible questions
Are process or outcome measures the best means for
neonatal services to evaluate their practice?
What specific measures should be audited?
Is adequacy of PN the right question?
Which processes (prescribing, preparing, dispensing,
delivering) require standardisation?
What is the research gap?
Optimal growth targets are not known
Preterm nutrition is
Controversial
Variable
Poorly evidenced
Focused on growth outcomes even though the
optimal pattern of growth is unknown
Optimal nutrient requirements for
preterm babies are not known
• Intrauterine nutrient provision
•
lipid - minimal
•
glucose - moderate
•
amino acid - high
• Postnatal nutrient provision
•
lipid - high
•
glucose - high
•
protein - low
Other dangers
Parenteral nutrition, (whether administered
centrally or peripherally) (IRR 13.8, 95% CI 8.5
to 22.3, p<0.001) and
gestational age < 26 weeks (IRR 2.4, 95% CI
1.7 to 3.5, p<0.001) are the highest significant
independent risk factors for newborn late onset
blood stream infection
(Modi et al 2006)
The tightrope of preterm nutrition support
Not too much, not too
little, but just right
NEON (Nutritional
Evaluation and
Optimisation in
Neonates trial)
commenced recruitment
June 2010
Our conclusions
The call to improve practice is welcomed
The focus on the newborn and on children is applauded
The need for consistency of prescribing, dispensing,
delivering and documenting is strongly supported
Preterm nutrition is experimental, research is needed
Beware the implementation of nutritional guidance that
lacks an evidence base
Food for thought
Target methodology to specific patient group
Denominator capture
Appropriate controls
A priori definition of “best practice”
Links to other initiatives
Specific audit recommendations
Delineation of the research gap